Physician profile
Amanda Phillips
NPI 1447290341
$4,960.13
in general payments reported to CMS, 2019-2025
35 companies · $15.33 in 2025
The $15.33 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $277 · 2021: $977 · 2022: $1,199 · 2023: $797 · 2024: $203 · 2025: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,207.95 | 2019-2022 | |
| Daiichi Sankyo INC. | $574.22 | 2019-2023 | Injectafer |
| Abbvie INC. | $521.07 | 2019-2023 | |
| Aspira Women'S Health INC | $352.99 | 2022 | |
| Novo Nordisk INC | $292.81 | 2021-2024 | Wegovy |
| Hologic Sales and Service, LLC | $264.74 | 2020-2023 | Aptima |
| Astellas Pharma US INC | $220.32 | 2021-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $212.21 | 2021-2023 | |
| Gynesonics, INC. | $146.45 | 2021 | |
| W. L. Gore & Associates, INC. | $125.00 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Agile Therapeutics, INC. | $115.73 | 2021-2022 | |
| Myriad Women'S Health, INC. | $113.62 | 2023 | Myrisk |
| Mylan Pharmaceuticals INC. | $101.27 | 2019-2022 | |
| Intuitive Surgical, INC. | $94.70 | 2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $57.88 | 2019-2024 | Paragard T 380a, Mara Console |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $57.30 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $46.66 | 2019-2021 | |
| Abbott Laboratories | $40.83 | 2022-2025 | Aveir |
| Pacira Pharmaceuticals Incorporated | $40.74 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $37.35 | 2023-2024 | Myfembree |
| Evofem Biosciences, INC. | $36.48 | 2021 | |
| Merck Sharp & Dohme LLC | $35.37 | 2019-2020 | |
| Therapeuticsmd, INC. | $34.35 | 2020 | |
| Myovant Sciences INC. | $30.48 | 2021-2022 | |
| Radius Health, INC. | $29.60 | 2020 | |
| Organon LLC | $28.95 | 2022-2023 | Nexplanon |
| Shield Therapeutics INC | $22.40 | 2023 | Accrufer |
| Becton, Dickinson and Company | $19.77 | 2023 | Bd Onclarity |
| Vertical Pharmaceuticals, LLC | $19.76 | 2019 | |
| Optumhealth Care Solutions, LLC | $17.64 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Scynexis, INC. | $14.28 | 2022 | |
| Avion Pharmaceuticals | $13.57 | 2022 | |
| Avanos Medical | $12.58 | 2019 | |
| Medicem INC. | $11.41 | 2020 | |
| Meditrina | $9.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.